Biotech IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update May 7, 2024
Biotech Capsida Biotherapeutics Presents New Preclinical Evidence Indicating Novel First-in-Class IV-Administered Gene Therapy Effectively Treats Genetic Epilepsy Due to STXBP1 Mutations May 7, 2024
Biotech Selvita completes acquisition of PozLab and significantly expands its drug development capabilities May 7, 2024
Biotech Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 May 7, 2024
Biotech 21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally May 6, 2024
Biotech Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals May 4, 2024
Biotech Media Advisory – Government of Canada to announce major investment in domestic biomanufacturing and life sciences sector May 4, 2024